NCT00358553View on ClinicalTrials.gov

A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Healthy

Interventions

DRUG

Insulin

Trial Locations (1)

Unknown

Profil, Neuss

All Listed Sponsors

lead

Baxter Healthcare Corporation

INDUSTRY

NCT00358553 - A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin | Biotech Hunter | Biotech Hunter